Online first articles
Articles not assigned to an issue 38 articles
-
-
Preventive effect of free radical scavenger edaravone lotion on cyclophosphamide chemotherapy-induced alopecia
Authors (first, second and last of 7)
- Takumi Tsuji
- Katsuaki Yoneda
- Takeyuki Kohno
- Content type: Short Communication
- Published: 20 April 2024
-
Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors
Authors (first, second and last of 9)
- Claire Miller
- Roberto Sommavilla
- Marie Cullberg
- Content type: Original Article
- Open Access
- Published: 20 April 2024
-
PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer
Authors (first, second and last of 7)
- Xianping Xu
- Yu Liu
- Zhibin Luo
- Content type: Original Article
- Published: 12 April 2024
-
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1
Authors (first, second and last of 22)
- Kiyoaki Uryu
- Yoshinori Imamura
- Hironobu Minami
- Content type: Original Article
- Published: 08 April 2024
This is part of 2 collections: -
Correction to: Phase I study of the anti‑TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors
Authors (first, second and last of 12)
- Noboru Yamamoto
- Takafumi Koyama
- Toshio Shimizu
- Content type: Correction
- Open Access
- Published: 31 March 2024
-
A polo-like kinase 1 inhibitor enhances erastin sensitivity in head and neck squamous cell carcinoma cells in vitro
Authors
- Xiangping Wu
- Jing Wu
- Content type: Original Article
- Open Access
- Published: 27 March 2024
-
Correction to: Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy
Authors
- Hongjie Huo
- Yu Feng
- Qiong Tang
- Content type: Correction
- Open Access
- Published: 26 March 2024
-
Postoperative chemotherapy relative dose intensity and overall survival in patients with colon cancer
Authors (first, second and last of 4)
- Justin C. Brown
- Jeffrey A. Meyerhardt
- Bette J. Caan
- Content type: Short Communication
- Published: 23 March 2024
-
Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects
Authors (first, second and last of 10)
- Sheng Ma
- Xin Wang
- Hua Zhang
- Content type: Regular Paper
- Published: 20 March 2024
-
Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation
Authors (first, second and last of 7)
- Lin-jie Ruan
- Ju-ying Jiao
- Zhen Chen
- Content type: Original Article
- Open Access
- Published: 19 March 2024
-
The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers
Authors (first, second and last of 10)
- Allison Dunn
- Naoko Takebe
- Jogarao V. S. Gobburu
- Content type: Original Article
- Published: 14 March 2024
-
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy
Authors (first, second and last of 12)
- Atsushi Ogawa
- Hiroshi Kawamoto
- Toshimi Kimura
- Content type: Original Article
- Open Access
- Published: 13 March 2024
-
Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment
Authors (first, second and last of 7)
- Nancy H.C. Loos
- Viët Bui
- Alfred H. Schinkel
- Content type: Original Article
- Published: 08 March 2024
-
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series
Authors (first, second and last of 12)
- Takashi Masuda
- Taro Funakoshi
- Atsushi Yonezawa
- Content type: Case Report
- Published: 08 March 2024
-
Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer
Authors (first, second and last of 8)
- Wei Zheng
- Wei Peng
- Xiaoying Fu
- Content type: Original Article
- Published: 08 March 2024
-
Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer
Authors (first, second and last of 6)
- Koutaro Ono
- Remi Murase
- Ken-ichi Fujita
- Content type: Original Article
- Published: 08 March 2024
-
Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with solid tumor cancer
Authors (first, second and last of 5)
- Guangnan Zong
- Jinlin Li
- Xiuli Guo
- Content type: Short Communication
- Published: 07 March 2024
-
Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors
Authors (first, second and last of 10)
- Colby S. Shemesh
- Yongsheng Wang
- Xian Wang
- Content type: Original Article
- Open Access
- Published: 07 March 2024
-
Correction to: Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants
Authors (first, second and last of 8)
- Romain Sechaud
- Helen Gu
- Hans D. Menssen
- Content type: Correction
- Published: 05 March 2024
-
Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients
Authors (first, second and last of 7)
- Jaya Shree Dilli Batcha
- Vikram Gota
- Surulivelrajan Mallayasamy
- Content type: Original Article
- Open Access
- Published: 05 March 2024
-
Successful use of Palbociclib combined with Venetoclax and Azacitidine in an adult with refractory/relapsed therapy-related acute myeloid leukemia
Authors (first, second and last of 9)
- Wenqiang Qu
- Jialing Lu
- Suning Chen
- Content type: Short Communication
- Published: 02 March 2024
-
Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data
Authors (first, second and last of 9)
- Cedric Lau
- Ma Ida Mohmaed Ali
- Alwin D. R. Huitema
- Content type: Original Article
- Open Access
- Published: 01 March 2024
-
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children’s Research Hospital
Authors (first, second and last of 9)
- Alyssa Gaietto
- John C Panetta
- Hope D Swanson
- Content type: Original Article
- Published: 28 February 2024
-
A first-in-human phase I study of TAS-117, an allosteric AKT inhibitor, in patients with advanced solid tumors
Authors (first, second and last of 14)
- Toshihiko Doi
- Shunji Takahashi
- Shinichi Okame
- Content type: Original Article
- Open Access
- Published: 27 February 2024
-
Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype
Authors
- John F. Marcelletti
- Branimir I. Sikic
- Content type: Original Article
- Published: 26 February 2024
-
Machine learning application identifies plasma markers for proteinuria in metastatic colorectal cancer patients treated with Bevacizumab
Authors (first, second and last of 4)
- Zhuoyuan Yu
- Haifan Xu
- Liqun Chen
- Content type: Original Article
- Published: 25 February 2024
-
18β-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis
Authors (first, second and last of 9)
- Xuan Ma
- Zhenou Sun
- Hongbo Hu
- Content type: Original Article
- Published: 21 February 2024
-
Multicenter randomized phase II study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases (YCOG1001)
Authors (first, second and last of 20)
- Mayumi Ozawa
- Jun Watanabe
- Itaru Endo
- Content type: Original Article
- Published: 19 February 2024
-
Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study
Authors (first, second and last of 9)
- Andrea René Jørgensen
- Mats Bue
- Maiken Stilling
- Content type: Original Article
- Open Access
- Published: 08 February 2024
-
Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer patients; a prospective clinical study
Authors (first, second and last of 7)
- Ahmed O. ELKasar
- Fatma Z. Hussien
- Adel R. Abd-Allah
- Content type: Original Article
- Published: 07 February 2024
-
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure
Authors (first, second and last of 10)
- Vikram Malhi
- Malgorzata Nowicka
- Jiajie Yu
- Content type: Short Communication
- Open Access
- Published: 02 February 2024
-
Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivity
Authors (first, second and last of 7)
- Qian Tan
- A. M. Joshua
- Ian F. Tannock
- Content type: Correction
- Published: 19 January 2024
-
Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors
Authors (first, second and last of 12)
- Noboru Yamamoto
- Takafumi Koyama
- Toshio Shimizu
- Content type: Short Communication
- Open Access
- Published: 11 January 2024
-
Evaluation of mycophenolic acid exposure in a patient with immune-related hepatotoxicity caused by nivolumab and ipilimumab therapy for malignant melanoma: a case report
Authors (first, second and last of 5)
- Yoshiharu Suzuki
- Shingo Ishiguro
- Mika Suzuki
- Content type: Short Communication
- Published: 26 December 2023
-
Azithromycin in cancer treatment: envisioning the probable link of mitochondrial dysfunction and necroptosis
Authors
- Siti Nazihahasma Hassan
- Farizan Ahmad
- Content type: Letter to the Editor
- Published: 14 November 2023
-
Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?
Authors (first, second and last of 9)
- Mourad Hamimed
- Raynier Devillier
- Samia Harbi
- Content type: Short Communication
- Published: 13 November 2023
-
Correction to: An IQ consortium analysis of starting dose selection for oncology small molecule first‑in‑patient trials suggests an alternative NOAEL‑based method can be safe while reducing time to the recommended phase 2 dose
Authors (first, second and last of 7)
- Bart A. Jessen
- Paul Cornwell
- Timothy Hart
- Content type: Correction
- Open Access
- Published: 29 September 2023
For authors
Submit manuscriptWorking on a manuscript?
Avoid the most common mistakes and prepare your manuscript for journal editors.
Learn more